Goldman Sachs Group Inc Rigel Pharmaceuticals Inc Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.12 - $1.57 $114,525 - $160,540	-102,255 Reduced 19.98%	409,482 $606,000
Q4 2023 Feb 13, 2024	SELL	$0.72 - $1.56 $52,905 - $114,628	-73,480 Reduced 12.56%	511,737 $742,000
Q3 2023 May 14, 2024	BUY	$1.07 - $1.39 $78,623 - $102,137	73,480 Added 14.36%	585,217 $632,000
Q3 2023 Nov 14, 2023	BUY	$1.07 - $1.39 $76,592 - $99,498	71,582 Added 13.94%	585,217 $632,000
Q2 2023 May 14, 2024	BUY	$1.12 - $1.82 $23,302 - $37,866	20,806 Added 4.22%	513,635 $662,000
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.82 $23,302 - $37,866	20,806 Added 4.22%	513,635 $662,000
Q1 2023 May 14, 2024	BUY	$1.25 - $2.0 $108,692 - $173,908	86,954 Added 21.42%	492,829 $650,000
Q1 2023 May 11, 2023	BUY	$1.25 - $2.0 $108,692 - $173,908	86,954 Added 21.42%	492,829 $650,000
Q4 2022 May 14, 2024	SELL	$0.67 - $11.9 $1.35 Million - $24 Million	-2,018,033 Reduced 83.26%	405,875 $608,000
Q4 2022 Feb 13, 2023	SELL	$0.67 - $11.9 $1.35 Million - $24 Million	-2,018,033 Reduced 83.26%	405,875 $608,000
Q3 2022 May 14, 2024	BUY	$1.1 - $12.2 $534,582 - $5.93 Million	485,984 Added 25.08%	2,423,908 $2.86 Million
Q3 2022 Nov 10, 2022	BUY	$1.1 - $12.2 $534,582 - $5.93 Million	485,984 Added 25.08%	2,423,908 $0
Q2 2022 May 14, 2024	BUY	$0.67 - $3.19 $955,545 - $4.55 Million	1,426,187 Added 278.7%	1,937,924 $2.19 Million
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $878,540 - $4.18 Million	1,311,254 Added 209.24%	1,937,924 $2.19 Million
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $2.57 Million - $3.99 Million	-1,156,650 Reduced 64.86%	626,670 $1.87 Million
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $1.35 Million - $2.03 Million	-569,967 Reduced 24.22%	1,783,320 $4.73 Million
Q3 2021 Nov 10, 2021	BUY	$3.5 - $4.5 $8.24 Million - $10.6 Million	2,353,287 New	2,353,287 $8.54 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account